As many of you know, Bill Cherman and I founded Repair Biotechnologies in 2018 with the intent of developing promising lines of rejuvenation research into clinical therapies. There are many opportunities given the present state of the science and far too few people working on them. This remains true even as large amounts of venture funding are entering the space; our field needs more entrepreneurs. I’m pleased to note that we’re making progress in our pipeline at Repair Biotechnologies, and have recently closed a seed round from notable investors in order to power us through to the next phase of our work. What does the Repair Biotechnologies team work on? When we initially set out, after a survey of the field, we settled upon regeneration of the thymus
From https://heidifrost.blogspot.com/2019/05/repair-biotechnologies-raises-215m-seed.html
from
https://heidifrost0.wordpress.com/2019/05/08/repair-biotechnologies-raises-a-2-15m-seed-round-to-fight-age-related-diseases/
No comments:
Post a Comment